DAPK enhances DDX20 protein stability via suppression of TRIM25-mediated ubiquitination-based DDX20 degradation

Yan Ye1,2,3, Xiuli Zhang1,2, Chenyi Wang4

  • 1College of Integrative Medicine, Fujian University of Traditional Chinese Medicine, Fuzhou, 350122, Fujian, China.

Cancer Cell International
|November 18, 2024
PubMed

Insights

Death-associated protein kinase (DAPK) stabilizes DDX20 by inhibiting TRIM25-mediated degradation, suppressing hepatocellular carcinoma (HCC) cell invasion. This reveals a new DAPK-TRIM25-DDX20 axis for HCC drug development.

Area of Science:

  • Molecular oncology
  • Cell signaling pathways

Background:

  • The DAPK-DDX20 axis shows anti-cancer activity in hepatocellular carcinoma (HCC) by inhibiting CDC42 GTPase activity, reducing cancer cell invasion and migration.
  • DAPK enhances DDX20 protein levels by suppressing its degradation, but the precise mechanism remains unclear.

Purpose of the Study:

  • To elucidate the mechanism by which DAPK regulates DDX20 stability.
  • To identify the E3 ubiquitin ligase responsible for DDX20 degradation.
  • To investigate the role of TRIM25 in the DAPK-DDX20 signaling pathway and its implications in HCC.

Main Methods:

  • Investigated DDX20 degradation via the ubiquitin-proteasome pathway.
  • Identified TRIM25 as the E3 ubiquitin ligase for DDX20 using binding and ubiquitination assays.
  • Analyzed the formation of a ternary complex involving DAPK, TRIM25, and DDX20.
  • Utilized shRNA to assess the functional impact of TRIM25 knockdown on cell migration and invasion.

Main Results:

  • DDX20 is degraded through the ubiquitin-proteasome pathway, with TRIM25 identified as the specific E3 ubiquitin ligase.
  • TRIM25 ubiquitinates DDX20 in the 1-244 amino acid region, promoting its proteasomal degradation.
  • DAPK interacts with the 1-244 region of DDX20, inhibiting ubiquitination and enhancing DDX20 stability.
  • DAPK, TRIM25, and DDX20 form a ternary complex; TRIM25 knockdown disrupts the DAPK-DDX20 complex.
  • TRIM25 functions as an oncogene in liver cancer, as its silencing inhibits cell migration and invasion.

Conclusions:

  • TRIM25 mediates the proteasomal degradation of DDX20, and DAPK stabilizes DDX20 by inhibiting this process.
  • The DAPK-TRIM25-DDX20 interaction reveals a novel regulatory mechanism in HCC.
  • TRIM25 acts as an oncogene in liver cancer, and targeting the DAPK-TRIM25-DDX20 axis offers potential therapeutic strategies for HCC.

Related Concept Videos

Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
2.8K
DNA Damage can Stall the Cell Cycle02:37

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.0K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
The Unfolded Protein Response01:37

The Unfolded Protein Response

The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
4.4K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.4K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K